Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST

NCT05970900 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumor of Rectum

Interventions

DRUG: Imatinib Mesylate
PROCEDURE: Local resection

Sponsor

Fujian Medical University Union Hospital